{"id": "test_0_0", "text": "Our work supported @GENE$ genetic variants as possible susceptibility factors for @DISEASE$ and fractures in humans.", "text_with_entity_marker": "Our work supported [E1]@GENE$[/E1] genetic variants as possible susceptibility factors for [E2]@DISEASE$[/E2] and fractures in humans.", "text_with_typed_entity_marker": "Our work supported [GENE]@GENE$[/GENE] genetic variants as possible susceptibility factors for [DISEASE]@DISEASE$[/DISEASE] and fractures in humans.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [19, 25], "entity_1_idx_in_text_with_entity_marker": [23, 29], "entity_1_idx_in_text_with_typed_entity_marker": [25, 31], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [82, 91], "entity_2_idx_in_text_with_entity_marker": [95, 104], "entity_2_idx_in_text_with_typed_entity_marker": [104, 113], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_1", "text": "Especially, the SNP @GENE$ and its strongly associated SNPs (e.g., rs1784235) could be important to human @DISEASE$ phenotypes.", "text_with_entity_marker": "Especially, the SNP [E1]@GENE$[/E1] and its strongly associated SNPs (e.g., rs1784235) could be important to human [E2]@DISEASE$[/E2] phenotypes.", "text_with_typed_entity_marker": "Especially, the SNP [GENE]@GENE$[/GENE] and its strongly associated SNPs (e.g., rs1784235) could be important to human [DISEASE]@DISEASE$[/DISEASE] phenotypes.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [20, 26], "entity_1_idx_in_text_with_entity_marker": [24, 30], "entity_1_idx_in_text_with_typed_entity_marker": [26, 32], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [106, 115], "entity_2_idx_in_text_with_entity_marker": [119, 128], "entity_2_idx_in_text_with_typed_entity_marker": [128, 137], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_2", "text": "Especially, the SNP rs491347 and its strongly associated SNPs (e.g., @GENE$) could be important to human @DISEASE$ phenotypes.", "text_with_entity_marker": "Especially, the SNP rs491347 and its strongly associated SNPs (e.g., [E1]@GENE$[/E1]) could be important to human [E2]@DISEASE$[/E2] phenotypes.", "text_with_typed_entity_marker": "Especially, the SNP rs491347 and its strongly associated SNPs (e.g., [GENE]@GENE$[/GENE]) could be important to human [DISEASE]@DISEASE$[/DISEASE] phenotypes.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [69, 75], "entity_1_idx_in_text_with_entity_marker": [73, 79], "entity_1_idx_in_text_with_typed_entity_marker": [75, 81], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [105, 114], "entity_2_idx_in_text_with_entity_marker": [118, 127], "entity_2_idx_in_text_with_typed_entity_marker": [127, 136], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_3", "text": "The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling @GENE$ level in carriers of @DISEASE$.", "text_with_entity_marker": "The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling [E1]@GENE$[/E1] level in carriers of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling [GENE]@GENE$[/GENE] level in carriers of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [93, 99], "entity_1_idx_in_text_with_entity_marker": [97, 103], "entity_1_idx_in_text_with_typed_entity_marker": [99, 105], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [121, 130], "entity_2_idx_in_text_with_entity_marker": [134, 143], "entity_2_idx_in_text_with_typed_entity_marker": [143, 152], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_4", "text": "Fetal haemoglobin (@GENE$) level modifies the clinical severity of @DISEASE$.", "text_with_entity_marker": "Fetal haemoglobin ([E1]@GENE$[/E1]) level modifies the clinical severity of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Fetal haemoglobin ([GENE]@GENE$[/GENE]) level modifies the clinical severity of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [19, 25], "entity_1_idx_in_text_with_entity_marker": [23, 29], "entity_1_idx_in_text_with_typed_entity_marker": [25, 31], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [67, 76], "entity_2_idx_in_text_with_entity_marker": [80, 89], "entity_2_idx_in_text_with_typed_entity_marker": [89, 98], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_5", "text": "@GENE$ (HbF) level modifies the clinical severity of @DISEASE$.", "text_with_entity_marker": "[E1]@GENE$[/E1] (HbF) level modifies the clinical severity of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] (HbF) level modifies the clinical severity of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [53, 62], "entity_2_idx_in_text_with_entity_marker": [66, 75], "entity_2_idx_in_text_with_typed_entity_marker": [75, 84], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_6", "text": "The @GENE$ intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of @DISEASE$.", "text_with_entity_marker": "The [E1]@GENE$[/E1] intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [129, 138], "entity_2_idx_in_text_with_entity_marker": [142, 151], "entity_2_idx_in_text_with_typed_entity_marker": [151, 160], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_7", "text": "The HBS1L-MYB intergenic region on chromosome @GENE$ is a quantitative trait locus controlling fetal haemoglobin level in carriers of @DISEASE$.", "text_with_entity_marker": "The HBS1L-MYB intergenic region on chromosome [E1]@GENE$[/E1] is a quantitative trait locus controlling fetal haemoglobin level in carriers of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "The HBS1L-MYB intergenic region on chromosome [GENE]@GENE$[/GENE] is a quantitative trait locus controlling fetal haemoglobin level in carriers of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [46, 52], "entity_1_idx_in_text_with_entity_marker": [50, 56], "entity_1_idx_in_text_with_typed_entity_marker": [52, 58], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [134, 143], "entity_2_idx_in_text_with_entity_marker": [147, 156], "entity_2_idx_in_text_with_typed_entity_marker": [156, 165], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_8", "text": "Functional studies to unravel the biological significance of this region in regulating @GENE$ production is clearly indicated, which may lead to new strategies to modify the disease course of severe @DISEASE$.", "text_with_entity_marker": "Functional studies to unravel the biological significance of this region in regulating [E1]@GENE$[/E1] production is clearly indicated, which may lead to new strategies to modify the disease course of severe [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Functional studies to unravel the biological significance of this region in regulating [GENE]@GENE$[/GENE] production is clearly indicated, which may lead to new strategies to modify the disease course of severe [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [87, 93], "entity_1_idx_in_text_with_entity_marker": [91, 97], "entity_1_idx_in_text_with_typed_entity_marker": [93, 99], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [199, 208], "entity_2_idx_in_text_with_entity_marker": [212, 221], "entity_2_idx_in_text_with_typed_entity_marker": [221, 230], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_9", "text": "IL-1, IL-1R and @GENE$ in Iranian patients with @DISEASE$.", "text_with_entity_marker": "IL-1, IL-1R and [E1]@GENE$[/E1] in Iranian patients with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "IL-1, IL-1R and [GENE]@GENE$[/GENE] in Iranian patients with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [16, 22], "entity_1_idx_in_text_with_entity_marker": [20, 26], "entity_1_idx_in_text_with_typed_entity_marker": [22, 28], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [48, 57], "entity_2_idx_in_text_with_entity_marker": [61, 70], "entity_2_idx_in_text_with_typed_entity_marker": [70, 79], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_10", "text": "On the other hand the frequency of @GENE$ genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), TNFalpha G -308 allele (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian @DISEASE$ patients.", "text_with_entity_marker": "On the other hand the frequency of [E1]@GENE$[/E1] genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), TNFalpha G -308 allele (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian [E2]@DISEASE$[/E2] patients.", "text_with_typed_entity_marker": "On the other hand the frequency of [GENE]@GENE$[/GENE] genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), TNFalpha G -308 allele (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian [DISEASE]@DISEASE$[/DISEASE] patients.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [35, 41], "entity_1_idx_in_text_with_entity_marker": [39, 45], "entity_1_idx_in_text_with_typed_entity_marker": [41, 47], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [395, 404], "entity_2_idx_in_text_with_entity_marker": [408, 417], "entity_2_idx_in_text_with_typed_entity_marker": [417, 426], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_11", "text": "On the other hand the frequency of IL-1alpha TT -889 genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), @GENE$ (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian @DISEASE$ patients.", "text_with_entity_marker": "On the other hand the frequency of IL-1alpha TT -889 genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), [E1]@GENE$[/E1] (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian [E2]@DISEASE$[/E2] patients.", "text_with_typed_entity_marker": "On the other hand the frequency of IL-1alpha TT -889 genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), [GENE]@GENE$[/GENE] (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian [DISEASE]@DISEASE$[/DISEASE] patients.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [138, 144], "entity_1_idx_in_text_with_entity_marker": [142, 148], "entity_1_idx_in_text_with_typed_entity_marker": [144, 150], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [390, 399], "entity_2_idx_in_text_with_entity_marker": [403, 412], "entity_2_idx_in_text_with_typed_entity_marker": [412, 421], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_12", "text": "@GENE$, IL-1R and TNFalpha gene polymorphisms in Iranian patients with @DISEASE$.", "text_with_entity_marker": "[E1]@GENE$[/E1], IL-1R and TNFalpha gene polymorphisms in Iranian patients with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE], IL-1R and TNFalpha gene polymorphisms in Iranian patients with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [71, 80], "entity_2_idx_in_text_with_entity_marker": [84, 93], "entity_2_idx_in_text_with_typed_entity_marker": [93, 102], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_13", "text": "Overall and relapse-free survival in @DISEASE$ and hypopharyngeal squamous cell carcinoma are associated with genotypes of @GENE$ gene.", "text_with_entity_marker": "Overall and relapse-free survival in [E1]@DISEASE$[/E1] and hypopharyngeal squamous cell carcinoma are associated with genotypes of [E2]@GENE$[/E2] gene.", "text_with_typed_entity_marker": "Overall and relapse-free survival in [DISEASE]@DISEASE$[/DISEASE] and hypopharyngeal squamous cell carcinoma are associated with genotypes of [GENE]@GENE$[/GENE] gene.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [37, 46], "entity_1_idx_in_text_with_entity_marker": [41, 50], "entity_1_idx_in_text_with_typed_entity_marker": [46, 55], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [123, 129], "entity_2_idx_in_text_with_entity_marker": [136, 142], "entity_2_idx_in_text_with_typed_entity_marker": [148, 154], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_0_14", "text": "Overall and relapse-free survival in oropharyngeal and @DISEASE$ are associated with genotypes of @GENE$ gene.", "text_with_entity_marker": "Overall and relapse-free survival in oropharyngeal and [E1]@DISEASE$[/E1] are associated with genotypes of [E2]@GENE$[/E2] gene.", "text_with_typed_entity_marker": "Overall and relapse-free survival in oropharyngeal and [DISEASE]@DISEASE$[/DISEASE] are associated with genotypes of [GENE]@GENE$[/GENE] gene.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [55, 64], "entity_1_idx_in_text_with_entity_marker": [59, 68], "entity_1_idx_in_text_with_typed_entity_marker": [64, 73], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [98, 104], "entity_2_idx_in_text_with_entity_marker": [111, 117], "entity_2_idx_in_text_with_typed_entity_marker": [123, 129], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_0_15", "text": "The @GENE$ SNP could be considered as a genetic marker to predict the clinical course of patients suffering from oropharyngeal and @DISEASE$.", "text_with_entity_marker": "The [E1]@GENE$[/E1] SNP could be considered as a genetic marker to predict the clinical course of patients suffering from oropharyngeal and [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] SNP could be considered as a genetic marker to predict the clinical course of patients suffering from oropharyngeal and [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [131, 140], "entity_2_idx_in_text_with_entity_marker": [144, 153], "entity_2_idx_in_text_with_typed_entity_marker": [153, 162], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_16", "text": "The @GENE$ SNP could be considered as a genetic marker to predict the clinical course of patients suffering from @DISEASE$ and hypopharyngeal cancer.", "text_with_entity_marker": "The [E1]@GENE$[/E1] SNP could be considered as a genetic marker to predict the clinical course of patients suffering from [E2]@DISEASE$[/E2] and hypopharyngeal cancer.", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] SNP could be considered as a genetic marker to predict the clinical course of patients suffering from [DISEASE]@DISEASE$[/DISEASE] and hypopharyngeal cancer.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [113, 122], "entity_2_idx_in_text_with_entity_marker": [126, 135], "entity_2_idx_in_text_with_typed_entity_marker": [135, 144], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_17", "text": "The prognostic value of the @GENE$ SNP was evaluated in an unselected series of patients treated with curative intent for @DISEASE$ and hypopharyngeal squamous cell carcinomas, including all tumor stages with different therapeutic regimens.", "text_with_entity_marker": "The prognostic value of the [E1]@GENE$[/E1] SNP was evaluated in an unselected series of patients treated with curative intent for [E2]@DISEASE$[/E2] and hypopharyngeal squamous cell carcinomas, including all tumor stages with different therapeutic regimens.", "text_with_typed_entity_marker": "The prognostic value of the [GENE]@GENE$[/GENE] SNP was evaluated in an unselected series of patients treated with curative intent for [DISEASE]@DISEASE$[/DISEASE] and hypopharyngeal squamous cell carcinomas, including all tumor stages with different therapeutic regimens.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [28, 34], "entity_1_idx_in_text_with_entity_marker": [32, 38], "entity_1_idx_in_text_with_typed_entity_marker": [34, 40], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [122, 131], "entity_2_idx_in_text_with_entity_marker": [135, 144], "entity_2_idx_in_text_with_typed_entity_marker": [144, 153], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_18", "text": "However, the majority of @DISEASE$ cells have deregulation of the @GENE$/beta-catenin pathway.", "text_with_entity_marker": "However, the majority of [E1]@DISEASE$[/E1] cells have deregulation of the [E2]@GENE$[/E2]/beta-catenin pathway.", "text_with_typed_entity_marker": "However, the majority of [DISEASE]@DISEASE$[/DISEASE] cells have deregulation of the [GENE]@GENE$[/GENE]/beta-catenin pathway.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [25, 34], "entity_1_idx_in_text_with_entity_marker": [29, 38], "entity_1_idx_in_text_with_typed_entity_marker": [34, 43], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [66, 72], "entity_2_idx_in_text_with_entity_marker": [79, 85], "entity_2_idx_in_text_with_typed_entity_marker": [91, 97], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_0_19", "text": "Lysophosphatidic acid facilitates proliferation of @DISEASE$ cells via induction of @GENE$.", "text_with_entity_marker": "Lysophosphatidic acid facilitates proliferation of [E1]@DISEASE$[/E1] cells via induction of [E2]@GENE$[/E2].", "text_with_typed_entity_marker": "Lysophosphatidic acid facilitates proliferation of [DISEASE]@DISEASE$[/DISEASE] cells via induction of [GENE]@GENE$[/GENE].", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [51, 60], "entity_1_idx_in_text_with_entity_marker": [55, 64], "entity_1_idx_in_text_with_typed_entity_marker": [60, 69], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [84, 90], "entity_2_idx_in_text_with_entity_marker": [97, 103], "entity_2_idx_in_text_with_typed_entity_marker": [109, 115], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_0_20", "text": "A recent study showed that LPA-mediated proliferation of @DISEASE$ cells requires activation of @GENE$.", "text_with_entity_marker": "A recent study showed that LPA-mediated proliferation of [E1]@DISEASE$[/E1] cells requires activation of [E2]@GENE$[/E2].", "text_with_typed_entity_marker": "A recent study showed that LPA-mediated proliferation of [DISEASE]@DISEASE$[/DISEASE] cells requires activation of [GENE]@GENE$[/GENE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [57, 66], "entity_1_idx_in_text_with_entity_marker": [61, 70], "entity_1_idx_in_text_with_typed_entity_marker": [66, 75], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [96, 102], "entity_2_idx_in_text_with_entity_marker": [109, 115], "entity_2_idx_in_text_with_typed_entity_marker": [121, 127], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_0_21", "text": "On multivariate analysis the @GENE$ (OR 8.205, 95% CI 1.616-41.667, p = 0.011) and smaller number of treatment cycles (OR 0.156, 95% CI 0.037-0.659, p = 0.011) were independent factors for @DISEASE$ (grade 3 or greater) throughout the period of chemotherapy.", "text_with_entity_marker": "On multivariate analysis the [E1]@GENE$[/E1] (OR 8.205, 95% CI 1.616-41.667, p = 0.011) and smaller number of treatment cycles (OR 0.156, 95% CI 0.037-0.659, p = 0.011) were independent factors for [E2]@DISEASE$[/E2] (grade 3 or greater) throughout the period of chemotherapy.", "text_with_typed_entity_marker": "On multivariate analysis the [GENE]@GENE$[/GENE] (OR 8.205, 95% CI 1.616-41.667, p = 0.011) and smaller number of treatment cycles (OR 0.156, 95% CI 0.037-0.659, p = 0.011) were independent factors for [DISEASE]@DISEASE$[/DISEASE] (grade 3 or greater) throughout the period of chemotherapy.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [29, 35], "entity_1_idx_in_text_with_entity_marker": [33, 39], "entity_1_idx_in_text_with_typed_entity_marker": [35, 41], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [189, 198], "entity_2_idx_in_text_with_entity_marker": [202, 211], "entity_2_idx_in_text_with_typed_entity_marker": [211, 220], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_22", "text": "The @GENE$, which is involved in the metabolism of vinblastine and doxorubicin, might be a genetic predictor of the severity of @DISEASE$ induced by chemotherapy with methotrexate, vinblastine, doxorubicin and cisplatin.", "text_with_entity_marker": "The [E1]@GENE$[/E1], which is involved in the metabolism of vinblastine and doxorubicin, might be a genetic predictor of the severity of [E2]@DISEASE$[/E2] induced by chemotherapy with methotrexate, vinblastine, doxorubicin and cisplatin.", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE], which is involved in the metabolism of vinblastine and doxorubicin, might be a genetic predictor of the severity of [DISEASE]@DISEASE$[/DISEASE] induced by chemotherapy with methotrexate, vinblastine, doxorubicin and cisplatin.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [128, 137], "entity_2_idx_in_text_with_entity_marker": [141, 150], "entity_2_idx_in_text_with_typed_entity_marker": [150, 159], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_23", "text": "@GENE$ genotyping might make tailor chemotherapy possible for @DISEASE$ patients treated with oxaliplatin-based chemotherapy.", "text_with_entity_marker": "[E1]@GENE$[/E1] genotyping might make tailor chemotherapy possible for [E2]@DISEASE$[/E2] patients treated with oxaliplatin-based chemotherapy.", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] genotyping might make tailor chemotherapy possible for [DISEASE]@DISEASE$[/DISEASE] patients treated with oxaliplatin-based chemotherapy.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [62, 71], "entity_2_idx_in_text_with_entity_marker": [75, 84], "entity_2_idx_in_text_with_typed_entity_marker": [84, 93], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_24", "text": "@GENE$ predicts overall survival of @DISEASE$ patients receiving oxaliplatin-based chemotherapy in Chinese population.", "text_with_entity_marker": "[E1]@GENE$[/E1] predicts overall survival of [E2]@DISEASE$[/E2] patients receiving oxaliplatin-based chemotherapy in Chinese population.", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] predicts overall survival of [DISEASE]@DISEASE$[/DISEASE] patients receiving oxaliplatin-based chemotherapy in Chinese population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [36, 45], "entity_2_idx_in_text_with_entity_marker": [49, 58], "entity_2_idx_in_text_with_typed_entity_marker": [58, 67], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_25", "text": "This study assessed associations between the @GENE$ gene and @DISEASE$ (MI), using a haplotype-based case-control study of 234 MI patients and 248 controls genotyped for 5 single-nucleotide polymorphisms (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200).", "text_with_entity_marker": "This study assessed associations between the [E1]@GENE$[/E1] gene and [E2]@DISEASE$[/E2] (MI), using a haplotype-based case-control study of 234 MI patients and 248 controls genotyped for 5 single-nucleotide polymorphisms (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200).", "text_with_typed_entity_marker": "This study assessed associations between the [GENE]@GENE$[/GENE] gene and [DISEASE]@DISEASE$[/DISEASE] (MI), using a haplotype-based case-control study of 234 MI patients and 248 controls genotyped for 5 single-nucleotide polymorphisms (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [45, 51], "entity_1_idx_in_text_with_entity_marker": [49, 55], "entity_1_idx_in_text_with_typed_entity_marker": [51, 57], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [61, 70], "entity_2_idx_in_text_with_entity_marker": [74, 83], "entity_2_idx_in_text_with_typed_entity_marker": [83, 92], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_26", "text": "A haplotype of the @GENE$ gene associated with @DISEASE$ in Japanese men.", "text_with_entity_marker": "A haplotype of the [E1]@GENE$[/E1] gene associated with [E2]@DISEASE$[/E2] in Japanese men.", "text_with_typed_entity_marker": "A haplotype of the [GENE]@GENE$[/GENE] gene associated with [DISEASE]@DISEASE$[/DISEASE] in Japanese men.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [19, 25], "entity_1_idx_in_text_with_entity_marker": [23, 29], "entity_1_idx_in_text_with_typed_entity_marker": [25, 31], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [47, 56], "entity_2_idx_in_text_with_entity_marker": [60, 69], "entity_2_idx_in_text_with_typed_entity_marker": [69, 78], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_27", "text": "For men, G allele frequency of @GENE$ and frequency of the T-C-G haplotype were significantly higher, and frequency of the T-C-A haplotype was significantly lower for @DISEASE$ patients than for controls (P=0.006, P=0.001 and P=0.002, respectively).", "text_with_entity_marker": "For men, G allele frequency of [E1]@GENE$[/E1] and frequency of the T-C-G haplotype were significantly higher, and frequency of the T-C-A haplotype was significantly lower for [E2]@DISEASE$[/E2] patients than for controls (P=0.006, P=0.001 and P=0.002, respectively).", "text_with_typed_entity_marker": "For men, G allele frequency of [GENE]@GENE$[/GENE] and frequency of the T-C-G haplotype were significantly higher, and frequency of the T-C-A haplotype was significantly lower for [DISEASE]@DISEASE$[/DISEASE] patients than for controls (P=0.006, P=0.001 and P=0.002, respectively).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [31, 37], "entity_1_idx_in_text_with_entity_marker": [35, 41], "entity_1_idx_in_text_with_typed_entity_marker": [37, 43], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [167, 176], "entity_2_idx_in_text_with_entity_marker": [180, 189], "entity_2_idx_in_text_with_typed_entity_marker": [189, 198], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_28", "text": "This study assessed associations between the @GENE$ gene and myocardial infarction (MI), using a haplotype-based case-control study of 234 @DISEASE$ patients and 248 controls genotyped for 5 single-nucleotide polymorphisms (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200).", "text_with_entity_marker": "This study assessed associations between the [E1]@GENE$[/E1] gene and myocardial infarction (MI), using a haplotype-based case-control study of 234 [E2]@DISEASE$[/E2] patients and 248 controls genotyped for 5 single-nucleotide polymorphisms (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200).", "text_with_typed_entity_marker": "This study assessed associations between the [GENE]@GENE$[/GENE] gene and myocardial infarction (MI), using a haplotype-based case-control study of 234 [DISEASE]@DISEASE$[/DISEASE] patients and 248 controls genotyped for 5 single-nucleotide polymorphisms (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200).", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [45, 51], "entity_1_idx_in_text_with_entity_marker": [49, 55], "entity_1_idx_in_text_with_typed_entity_marker": [51, 57], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [139, 148], "entity_2_idx_in_text_with_entity_marker": [152, 161], "entity_2_idx_in_text_with_typed_entity_marker": [161, 170], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_29", "text": "When stratified by @GENE$ polymorphism, alcohol-related increases in @DISEASE$ risk were restricted to individuals with the AG/GG genotypes, with a more than 2-fold risk among daily drinkers (OR=2.63, 95% CI=1.00-6.88) and 3-fold risk (OR=3.66, 95% CI=1.19-11.24) among those with 40 or more drink-years.", "text_with_entity_marker": "When stratified by [E1]@GENE$[/E1] polymorphism, alcohol-related increases in [E2]@DISEASE$[/E2] risk were restricted to individuals with the AG/GG genotypes, with a more than 2-fold risk among daily drinkers (OR=2.63, 95% CI=1.00-6.88) and 3-fold risk (OR=3.66, 95% CI=1.19-11.24) among those with 40 or more drink-years.", "text_with_typed_entity_marker": "When stratified by [GENE]@GENE$[/GENE] polymorphism, alcohol-related increases in [DISEASE]@DISEASE$[/DISEASE] risk were restricted to individuals with the AG/GG genotypes, with a more than 2-fold risk among daily drinkers (OR=2.63, 95% CI=1.00-6.88) and 3-fold risk (OR=3.66, 95% CI=1.19-11.24) among those with 40 or more drink-years.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [19, 25], "entity_1_idx_in_text_with_entity_marker": [23, 29], "entity_1_idx_in_text_with_typed_entity_marker": [25, 31], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [69, 78], "entity_2_idx_in_text_with_entity_marker": [82, 91], "entity_2_idx_in_text_with_typed_entity_marker": [91, 100], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_30", "text": "The @GENE$ gene at 7q22.1 has been shown to be associated with familial intracranial aneurysms (@DISEASE$) in the Japanese population.", "text_with_entity_marker": "The [E1]@GENE$[/E1] gene at 7q22.1 has been shown to be associated with familial intracranial aneurysms ([E2]@DISEASE$[/E2]) in the Japanese population.", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] gene at 7q22.1 has been shown to be associated with familial intracranial aneurysms ([DISEASE]@DISEASE$[/DISEASE]) in the Japanese population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [96, 105], "entity_2_idx_in_text_with_entity_marker": [109, 118], "entity_2_idx_in_text_with_typed_entity_marker": [118, 127], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_31", "text": "The @GENE$ gene at 7q22.1 has been shown to be associated with familial @DISEASE$ (IAs) in the Japanese population.", "text_with_entity_marker": "The [E1]@GENE$[/E1] gene at 7q22.1 has been shown to be associated with familial [E2]@DISEASE$[/E2] (IAs) in the Japanese population.", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] gene at 7q22.1 has been shown to be associated with familial [DISEASE]@DISEASE$[/DISEASE] (IAs) in the Japanese population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [72, 81], "entity_2_idx_in_text_with_entity_marker": [85, 94], "entity_2_idx_in_text_with_typed_entity_marker": [94, 103], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_32", "text": "The @GENE$ polymorphism of COL1A2 could be a genetic risk factor for sporadic @DISEASE$ among individuals of Chinese Han ethnicity.", "text_with_entity_marker": "The [E1]@GENE$[/E1] polymorphism of COL1A2 could be a genetic risk factor for sporadic [E2]@DISEASE$[/E2] among individuals of Chinese Han ethnicity.", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] polymorphism of COL1A2 could be a genetic risk factor for sporadic [DISEASE]@DISEASE$[/DISEASE] among individuals of Chinese Han ethnicity.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [78, 87], "entity_2_idx_in_text_with_entity_marker": [91, 100], "entity_2_idx_in_text_with_typed_entity_marker": [100, 109], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_33", "text": "This study is the first to confirm the association between @GENE$ and @DISEASE$.", "text_with_entity_marker": "This study is the first to confirm the association between [E1]@GENE$[/E1] and [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "This study is the first to confirm the association between [GENE]@GENE$[/GENE] and [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [59, 65], "entity_1_idx_in_text_with_entity_marker": [63, 69], "entity_1_idx_in_text_with_typed_entity_marker": [65, 71], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [70, 79], "entity_2_idx_in_text_with_entity_marker": [83, 92], "entity_2_idx_in_text_with_typed_entity_marker": [92, 101], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_34", "text": "Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of @GENE$ but protects against @DISEASE$.", "text_with_entity_marker": "Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of [E1]@GENE$[/E1] but protects against [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of [GENE]@GENE$[/GENE] but protects against [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [97, 103], "entity_1_idx_in_text_with_entity_marker": [101, 107], "entity_1_idx_in_text_with_typed_entity_marker": [103, 109], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [125, 134], "entity_2_idx_in_text_with_entity_marker": [138, 147], "entity_2_idx_in_text_with_typed_entity_marker": [147, 156], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_35", "text": "Surprisingly, the @GENE$ allele is associated with a decreased incidence of @DISEASE$, suggesting that Mycobacterium leprae subverts the TLR system as a mechanism of immune evasion.", "text_with_entity_marker": "Surprisingly, the [E1]@GENE$[/E1] allele is associated with a decreased incidence of [E2]@DISEASE$[/E2], suggesting that Mycobacterium leprae subverts the TLR system as a mechanism of immune evasion.", "text_with_typed_entity_marker": "Surprisingly, the [GENE]@GENE$[/GENE] allele is associated with a decreased incidence of [DISEASE]@DISEASE$[/DISEASE], suggesting that Mycobacterium leprae subverts the TLR system as a mechanism of immune evasion.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [18, 24], "entity_1_idx_in_text_with_entity_marker": [22, 28], "entity_1_idx_in_text_with_typed_entity_marker": [24, 30], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [76, 85], "entity_2_idx_in_text_with_entity_marker": [89, 98], "entity_2_idx_in_text_with_typed_entity_marker": [98, 107], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_0_36", "text": "These results suggest that combination of HDACi with adenoviral @GENE$ gene therapy may be a new therapeutic approach for the treatment of @DISEASE$ that warrants further investigation.", "text_with_entity_marker": "These results suggest that combination of HDACi with adenoviral [E1]@GENE$[/E1] gene therapy may be a new therapeutic approach for the treatment of [E2]@DISEASE$[/E2] that warrants further investigation.", "text_with_typed_entity_marker": "These results suggest that combination of HDACi with adenoviral [GENE]@GENE$[/GENE] gene therapy may be a new therapeutic approach for the treatment of [DISEASE]@DISEASE$[/DISEASE] that warrants further investigation.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [64, 70], "entity_1_idx_in_text_with_entity_marker": [68, 74], "entity_1_idx_in_text_with_typed_entity_marker": [70, 76], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [139, 148], "entity_2_idx_in_text_with_entity_marker": [152, 161], "entity_2_idx_in_text_with_typed_entity_marker": [161, 170], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
